DJIA 16,058.35 -469.68 -2.84%
NASDAQ 4,636.11 -140.40 -2.94%
S&P 500 1,913.85 -58.33 -2.96%
market minute promo

Alkermes, Inc. (NASDAQ: ALKS)

59.41 -0.15 (-0.25%)

Quote as of


company name or ticker

Recent Quotes

ALKS $59.41 -0.25%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $61.43
Previous Close $59.56
Daily Range $59.05 - $63.03
52-Week Range $38.49 - $75.17
Market Cap $8.9B
P/E Ratio -100.95
Dividend (Yield) $0.00 (0.0%)
Volume 1,440,087
Average Daily Volume 796,719
Current FY EPS -$0.93

Sector

Healthcare

Industry

Drug Makers

Alkermes, Inc. (ALKS) Description

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease. Website: http://www.alkermes.com/

News & Commentary

Why I Think Alkermes Could Be a Top Performing Stock Ahead of 2016

Upcoming catalysts including new drugs for schizophrenia and depression could send Alkermes shares soaring.

Today's Dead Cat Bounce Stock Is Alkermes (ALKS)

Benzinga's Volume Movers

Morning Market Gainers

New Ratings on American Airlines, Delta and 8 Other Stocks -- Analysts' Actions

Top Analyst Upgrades and Downgrades: American Airlines, CyberArk, Delta Air, First Solar, VMware and

Top Analyst Upgrades and Downgrades: American Airlines, CyberArk, Delta Air, First Solar, VMware and Many More

Credit Suisse's 8 Pharmaceutical Stocks with 'Significant' Upside

Biotech Stock Roundup: Acorda Gains on Patent Issues, Vital Crushed by Liver Data

Alkermes' (ALKS) Aristada Review Date Postponed by FDA

ALKS Crosses Below Key Moving Average Level

Alkermes' Reports Wider Q2 Loss, Increases Guidance - Analyst Blog

See More ALKS News...

ALKS's Top Competitors

ALKS $59.41 (-0.25%)
Current stock: ALKS
CELG $115.46 (-2.22%)
Current stock: CELG
BIIB $292.50 (-1.61%)
Current stock: BIIB
GILD $101.49 (-3.41%)
Current stock: GILD